This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Dopamine Receptor Story

Philip Seeman, MD, PhD

Arch Neurol. 1993;50(10):1093-1095.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Just under 1% of the world population has schizophrenia, a disease that continues to be unyielding in the search for its biological cause. Despite not knowing the mysterious origins of this life-long illness starting in young adults, the symptoms of delusions and hallucinations generally respond to medication with any of the antipsychotic drugs such as haloperidol, chlorpromazine, remoxipride, risperidone, clozapine, and thioridazine. Early intervention in young psychotic adults leads to early response within days. Late intervention, after months or years of neglecting the symptoms, leads to a much slower response of 1 to 2 months. This author's speculation is that while there may be specific brain regions (to be discovered) that are "schizophreno-genic," the longer the psychotic symptoms go untreated, the longer such psychotic brain regions drive and "kindle" the various memory and integration systems of the rest of the brain. Such kindling, as in epileptic kindling, would only serve . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Pharmacology and Psychiatry, University of Toronto (Ontario).

Footnotes
Accepted for publication December 10, 1992.

Reprint requests to Departments of Pharmacology and Psychiatry, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada MSS 1 A8 (Dr Seeman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?